Form 4 holding
10%+ Owner
Zenas BioPharma, Inc.
- Security class
- Common Stock
- Shares / value
- 3,761,359
- Estimated value
- $63,943,103
- Report date
- 16 Sep 2024
- Price
- $17.00
- Ownership
- By Zebra Aggregator, LP
Enavate Sciences GP, LLC
Insider Reports History
- Reporting-owner location
- New York, NY
- Latest reporting-owner signature
-
Enavate Sciences GP, LLC, By: /s/ James P. Boylan, Manager
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Enavate Sciences GP, LLC
Form 4 holding
10%+ Owner
Camp4 Therapeutics Corp
- Security class
- Common Stock
- Shares / value
- 3,785,802
- Estimated value
- Report date
- 15 Oct 2024
- Price
- Ownership
- By Everest Aggregator, LP
Form 4 holding
10%+ Owner
Camp4 Therapeutics Corp
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 15 Oct 2024
- Price
- Ownership
- By Everest Aggregator, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Zenas BioPharma, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2024
- Price
- Ownership
- By Zebra Aggregator, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Zenas BioPharma, Inc.
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2024
- Price
- Ownership
- By Zebra Aggregator, LP
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Enavate Sciences GP, LLC
4
CAMP
Camp4 Therapeutics Corp
- Report period
- 15 Oct 2024
- Transactions
- 3
- Transaction value
- +$14,999,996
- Accepted by SEC
- 17 Oct 2024, 16:15
- Role
- 10%+ Owner
- Next action
- Open filing details
3
CAMP
Camp4 Therapeutics Corp
- Report period
- 10 Oct 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 10 Oct 2024, 21:22
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ZBIO
Zenas BioPharma, Inc.
- Report period
- 16 Sep 2024
- Transactions
- 4
- Transaction value
- +$15,000,001
- Accepted by SEC
- 18 Sep 2024, 16:15
- Role
- 10%+ Owner
- Next action
- Open filing details
3
ZBIO
Zenas BioPharma, Inc.
- Report period
- 12 Sep 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 12 Sep 2024, 21:38
- Role
- 10%+ Owner
- Next action
- Open filing details